The Nose Knows: Why NeOnc’s Patent Portfolio Could Make NTHI More Than a One-Drug Biotech
Go back to The Nose Knows: Why NeOnc’s Patent Portfolio Could Make NTHI More Than a One-Drug Biotech| (NASDAQ: NTHI) | Delayed: 3.62 -0.45 (11.06%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.07 | 52 Week High | $ | |||
| Open | $4.00 | 52 Week Low | $ | |||
| Day High | $4.00 | P/E | N/A | |||
| Day Low | $3.46 | EPS | $ | |||
| Volume | 299,184 | |||||

